Shanghai Pharmaceuticals Holding Co. Ltd. Class A 601607

SSE · China · Health Technology

CNY 16.22+0.22 (+1.37%)

Market closed· Sep 30, 2026, 7:00 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Shanghai Pharmaceuticals Holding Co. Ltd. Class A 601607

SSE · China · Health Technology

CNY 16.22+0.22 (+1.37%)

Market closed· Sep 30, 2026, 7:00 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-3.45% · 6MFull-screen chart

Open CNY 16.00High CNY 16.28Low CNY 15.99Close CNY 16.22Volume 11.42M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CNY 16.00
Day range: CNY 15.99 – CNY 16.28
52-week range: CNY 15.01 – CNY 18.56
Volume: 11.42M
Market cap: CNY 54.00B
P/E (TTM): 12.6
Dividend yield (annualized): 2.77%
Next earnings date: 2026-10-30
Avg. volume (1Y): 12.26M

Performance

1 week

+1.00%

1 month

+0.44%

3 months

+4.67%

6 months

-3.74%

Year to date

-6.65%

1 year

-6.54%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: China
Exchange: SSE
Shares outstanding: 2.79B
Employees: 49,608
ISIN: CNE000000C82
Beta: 0.43

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceSep 17, 2026

Shanghai Pharmaceuticals Holding Co Ltd's Dividend Analysis

Shanghai Pharmaceuticals Holding Co Ltd (SHPMY) recently announced a total dividend of $0.07 per share, with the ex-dividend date set for 2026-09-17. This amount consists of a $0.07 per share cash dividend, payable on 2026-11-12. For investors, the ex-dividend date is a key marker: shareholders must own the stock before this date to qualify for the payment, while the pay date indicates when the cash actually reaches accounts.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.